Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
Iressa,
Irinotecan Drug Interactions: Focus On The P450 Microenzyme System Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Nursing Considerations and Drug Information Protein Kinase Inhibitors References (Chapter 2) References (Chapter 3)
Isoenzymes, drug metabolism and
Ispinesib (SB-715992) Mitotic Kinase Inhibitors Summary (Chapter 4)
Jagged1 Antiangiogenic Drug Therapy References (Chapter 3) Targeting Angiogenesis
Jain, R. K.
JAK Glossary Protein Kinase Signaling Pathways
JNK Application Of The Hallmarks Of Cancer Bone Metastasis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Protein Kinase Signaling Pathways References (Chapter 2)
JNK pathways,
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, 2003 Seventh Report of
Jun-N-terminal kinase pathways Bone Metastasis Protein Kinase Signaling Pathways
Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Insulin-Like Growth Factor Receptor Pathway Targets
Kinesin spindle protein inhibitors Mitotic Kinase Inhibitors Summary (Chapter 4)
KRAS gene Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) References (Chapter 2)
K-ras mutations Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Protein Kinase Signaling Pathways References (Chapter 2)
KRAS signaling, in colorectal cancer
KSP inhibitors,
Lacouture, M. E.
Lamellipodia
Lapatinib (Tykerb, GW-572016)
Lapenna, S.
Lash, T. L.
Left ventricular ejection fraction Glossary Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies Nursing Considerations and Drug Information
Lenalidomide (Revlimid)
Lenz, H. J.
Letrozole
Leucovorin Application Of The Hallmarks Of Cancer Drug Interactions: Focus On The P450 Microenzyme System Nursing Considerations and Drug Information References (Chapter 3)
LFTs,
Ligand binding Bone Metastasis Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets EGFR pathway targeting and Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways) Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Pharmacologic Management Targeting Apoptosis turning off HER family activity in cancer cells and
Ligands Application Of The Hallmarks Of Cancer Bone Metastasis Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Hypoxia-Inducible Factor, Mtor, and Angiogenesis Invasion and Metastasis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) neutralization of References (Chapter 3) Targeting Angiogenesis Targeting Apoptosis turning on EGFR and EGF with